← Leaderboards
Mendel Tuchman
University Of Minnesota Twin Cities
$17,307,232
Attributed
$17,543,732
Total exposure
22
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–16$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$18,793,732 · 23
By mechanism
R01$12,454,475 · 3
U54$2,659,954 · 5
K12$2,632,907 · 1
R21$473,000 · 1
P20$267,099 · 3
P01$212,408 · 1
Top collaborators
- Ljubica Morizono Caldovic2 shared
Others in their field
Top investigators on “Hyperammonemia”
- Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru$8,503,682
- Brendan Hl Lee · Baylor College Of Medicine$7,656,229
- Mark L Batshaw · Children'S Research Institute$7,142,597
- Gerald S Lipshutz · University Of California Los Angeles$7,045,125
- Marylaura Lind Thomas · Sequitur Health Corp.$6,163,467
- Charles Alfred Stanley · Children'S Hospital Of Philadelphia$5,097,484
Research focus
HyperammonemiaCarbamyl PhosphateUrea CycleLigaseN Acetyl L GlutamateGlutamatesAmmoniaUreaBiochemicalDefectN-CarbamylglutamateLiverCessation Of LifeBrain InjuriesInheritedInvestigationAnalogDevelopmental DisabilitiesClinical ResearchBloodIn VivoKetotic HyperglycinemiaBrainGlutamine
Grant awards (64)
N-carbamylglutamate in the treatment of hyperammonemia$645,489
R01 · FY2016 · HD · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$357,770
R01 · FY2016 · DK · contact PI
Rare Diseases Clinical Research Consortia (RDCRC) for the RDCR Network$1,250,000
U54 · FY2015 · HD · contact PI
Longitudinal Study of Urea Cycle Disorders$656,098
U54 · FY2015 · HD · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$635,709
R01 · FY2015 · HD · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$355,814
R01 · FY2015 · DK · contact PI
Overall Adminstration of Rare Diseases Clinical Research Consortia (RDCRC)$257,803
U54 · FY2015 · HD · contact PI
Pilot/Demonstration Clinical Research Projects Program$50,000
U54 · FY2015 · HD · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$635,208
R01 · FY2014 · HD · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$367,770
R01 · FY2014 · DK · contact PI
Neuroprotection from hyperammonemia: small molecule screen$215,000
R21 · FY2014 · DK · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$685,649
R01 · FY2013 · HD · contact PI
Neuroprotection from hyperammonemia: small molecule screen$258,000
R21 · FY2013 · DK · contact PI
N-Carbamylglutamate in the Treatment of Hyperammonemia$77,313
U54 · FY2013 · HD · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$831,186
R01 · FY2012 · HD · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$328,065
R01 · FY2012 · DK · contact PI
N-Carbamylglutamate in the Treatment of Hyperammonemia$81,467
U54 · FY2012 · HD · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$328,065
R01 · FY2011 · DK · contact PI
N-Carbamylglutamate in the Treatment of Hyperammonemia$82,917
U54 · FY2011 · HD · contact PI
The molecular bases of inherited urea cycle disorders and ureagenesis regulation$332,667
R01 · FY2010 · DK · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$331,379
R01 · FY2010 · DK · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$323,370
R01 · FY2010 · HD · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$99,844
R01 · FY2010 · DK · contact PI
N-Carbamylglutamate in the Treatment of Hyperammonemia$83,755
U54 · FY2010 · HD · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$10,664
R01 · FY2010 · HD · contact PI
N-CARBAMYLGLUTAMATE (CARBAGLU) IN THE TREATMENT OF HYPERAMMONEMIA$8,808
M01 · FY2010 · RR · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$558,800
R01 · FY2009 · DK · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$341,326
R01 · FY2009 · DK · contact PI
The molecular bases of inherited urea cycle disorders and ureagenesis regulation$336,027
R01 · FY2009 · DK · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$326,785
R01 · FY2009 · HD · contact PI
N-Carbamylglutamate in the Treatment of Hyperammonemia$120,601
U54 · FY2009 · HD · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$10,664
R01 · FY2009 · HD · contact PI
N-CARBAMYLGLUTAMATE (CARBAGLU) IN THE TREATMENT OF HYPERAMMONEMIA$3,499
M01 · FY2009 · RR · contact PI
N-acetylglutamate Synthase: Structure, Function & Defects$344,626
R01 · FY2008 · DK · contact PI
N-carbamylglutamate in the treatment of hyperammonemia$343,428
R01 · FY2008 · HD · contact PI
The molecular bases of inherited urea cycle disorders and ureagenesis regulation$338,610
R01 · FY2008 · DK · contact PI
The molecular bases of inherited urea cycle disorders and ureagenesis regulation$348,155
R01 · FY2007 · DK · contact PI
The molecular bases of inherited urea cycle disorders$358,553
R01 · FY2006 · DK · contact PI
PLANNING GRANT: WASHINGTON CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE$267,099
P20 · FY2006 · RR · contact PI
N-acetylglutamate synthase: structure, & defects$246,743
R01 · FY2006 · DK · contact PI
N-CARAMYLGLUTAMATE (CARBAGLU): EFFECT ON UREAGENESIS IN N-ACETYLGLUTAMATE$1,859
M01 · FY2006 · RR · contact PI
N-acetylglutamate synthase: structure, &defects$309,225
R01 · FY2005 · DK
Molecular Basis of OTC Deficiency and Related Disorders$288,591
R01 · FY2005 · DK
RARE DISEASE CLINICAL RESEARCH CENTER- UREA CYCLE DISORDERS$56,742
M01 · FY2005 · RR
PHARMACOKINETICS OF ORAL SODIUM-PHENYLBUTYRATE$4,045
M01 · FY2005 · RR
IN VIVO NITROGEN INCORPORATION INTO UREA$3,236
M01 · FY2005 · RR
Pediatric Clinical Research Scholar Program - Washington$1,154,042
K12 · FY2004 · RR
N-acetylglutamate synthase: structure, &defects$301,147
R01 · FY2004 · DK
Molecular Basis of OTC Deficiency and Related Disorders$280,189
R01 · FY2004 · DK
Blood Spot Assay of Ammonia Scavenger Drugs$350
M01 · FY2004 · RR
In Vitro Nitrogen Incorporation Into Urea$350
M01 · FY2004 · RR
Pediatric Clinical Research Scholar Program - Washington$938,566
K12 · FY2003 · RR
Molecular Basis of OTC Deficiency and Related Disorders$311,401
R01 · FY2003 · DK
N-acetylglutamate synthase: structure, &defects$308,381
R01 · FY2003 · DK
Pediatric Clinical Research Scholar Program - Washington$540,299
K12 · FY2002 · RR
Molecular Basis of OTC Deficiency and Related Disorders$338,129
R01 · FY2002 · DK
CORE--SHARED RESOURCE CORE$0
P20 · FY2002 · MD
CORE--SHARED RESOURCE CORE$0
P20 · FY2002 · MD
MOLECULAR BASIS OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY$251,182
R01 · FY2001 · DK
THERAPY FOR HYPERAMMONEMIA WITH GENE ENGINEERED BACTERIA$106,204
P01 · FY2001 · HD
Society for Inherited Metabolic Disorders 2001 meeting$15,000
R13 · FY2001 · DK
THERAPY FOR HYPERAMMONEMIA WITH GENE ENGINEERED BACTERIA$0
P01 · FY2001 · HD
MOLECULAR BASIS OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY$243,864
R01 · FY2000 · DK
THERAPY FOR HYPERAMMONEMIA WITH GENE ENGINEERED BACTERIA$106,204
P01 · FY2000 · HD